Riskpilot← Back to searchSign inGet full accessNAPRAPATENE MIDT-NORGE AS
ASActiveOrg 996864081Sigmunds Vei 2A, 7041 TrondheimAndre helsetjenester · NACE 86909Est. 20110 employees
Revenue 2022
NOK 0
EBITDA margin
—
-139% vs 2021
Equity ratio
94.4%
Financial strength
Net profit 2022
NOK -35K
-303% vs 2021
| Revenue | NOK 0 | — |
| EBITDA | NOK -21K | -139% |
| Net profit | NOK -35K | -303% |
| Total assets | NOK 123K | -25% |
| Equity | NOK 116K | -23% |
| Employees | 0 | — |
Legal name
NAPRAPATENE MIDT-NORGE AS
Org number
996864081
Legal form
Aksjeselskap
NACE code
86909 · Andre helsetjenester
Founded
30. april 2011
Share capital
NOK 10 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg. Daglig leder alene.
Company purpose
Tilby tjenester innen fysikalsk behandling og undervisning, samt kjøp og salg av varer.
Address
Sigmunds Vei 2A, 7041 Trondheim
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −10 | −8 | −7 | −9 | −21 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −10 | −8 | −7 | −9 | −21 |
| Net financials | 0 | 0 | 0 | −0 | −14 |
| Profit before tax | −9 | −8 | −7 | −9 | −35 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −9 | −8 | −7 | −9 | −35 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 182 | 175 | 168 | 163 | 123 |
| Equity | 174 | 166 | 159 | 151 | 116 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 8 | 8 | 9 | 12 | 7 |
| Total debt | 8 | 8 | 9 | 12 | 7 |
EBITDA margin
-2058600.0%
This company
15.8%
Market median
-13029214% vs market
20182022
Equity ratio
94.4%
This company
38.2%
Market median
+147% vs market
20182022
Return on equity
-30.0%
This company
18.4%
Market median
-263% vs market
20182022
Net profit margin
-3481800.0%
This company
8.1%
Market median
-42985285% vs market
20182022
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20182022
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20182022
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AW Deputy Member | Deputy Member | 2011 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2011 | |
| Board of Directors | 2011 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50% | 50% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NAPRAPATENE MIDT-NORGE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Arild Witzø | Deputy Member | 0 companies |
| Hanna Marianne Latha Larsson | Chairman | 0 companies |
| Arne Witzø | Board of Directors | 0 companies |